CBIO
Crescent Biopharma, Inc. · Healthcare
Fairmount Funds Management LLC bought $12.4M of Crescent Biopharma, Inc.
Director
Bought$12,375,025
$14.50Price
853,450Shares
+31%Stake
What CBIO did for a copier
- $1,000 copied at Tue, Jul 21 open, $16.37
- $1,133
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Sep 2 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −8.5% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jul 16. Filed Mon, Jul 20, 5:30 PM ET, after the close. Returns use the Jul 21 open and the Sep 2 close. Not investment advice.